Biocredit Rapigen One Step Rapid Test

Biocredit Covid-19 Ag tuvastuskomplekt

SKU: G61RHA20

SAADAVUS: Varud madalaima väärtusega turul

TARNIMINE: Sarnased päevased kaubatellimused varem kui 14

H00SIZE: 20 eksamit/komplekt SPECIFICITY: 98,90%

Sorteeri

Immunokromatograafia kiire kontroll

Kirjeldus

Külgliikumise immunokromatograafiline test, mis võttis kasutusele kaksikvärvisüsteemi.
SARS-CoV-2 antigeeni kvalitatiivseks tuvastamiseks ninaneelu tampooniproovist.
Kontroll sisaldab kolloidkullaga konjugaatpadja ja membraaniriba, mis on eelnevalt kaetud kontrolljälgedel (T) olevate SARS-CoV-2 antigeeni spetsiifiliste antikehadega.
Kontrolljälgedel tundub visuaalselt must riba (antikeha-antigeeni-antikeha kuldkonjugaat on keeruline) (T) Kui proovis on SARS-CoV-2 antigeen.
Juhtimisliin (C) näitab, et kontroll viiakse läbi nõuetekohaselt.
Hinnatud paneeliprooviga (n = 75) PCR järgi
Tundlikkus: 90,2 %
Spetsiifilisus: 100 %

VITROS SARS CoV2 antigeeni CLIA juhtimine, mis põhineb peamiselt Ortho Medicali kontrollil

Diagnostika

1. VITROS SARS CoV2 antigeeni test on kemoluminestseeruv immuunanalüüs, mis on ette nähtud
SARS-CoV-2 nukleokapsiidi antigeenide kvalitatiivseks tuvastamiseks nina-neelu (NP) proovides inimestelt, kellel
kahtlustatakse COVID-19 ühe kuni viie päeva jooksul pärast sümptomite ilmnemist. või
asümptomaatilistelt inimestelt kogutud turba keskel olevad isendid .
2. Analüüs tuleks läbi viia VITROS 3600 immunodiagnostikasüsteemis või VITROS 5600 / VITROS XT 7600
sisseehitatud süsteemis firmalt Ortho.

Funktsioonid

COVID-19, ninaneelu tampoonid

Kalibreerimisviis

Kvalitatiivne

Biokrediidi antigeeni kontroll

Biocredit Antigen Test
Biocredit Antigen Test

VITROS SARS CoV2 antigeeni test – protseduurilised sammud: –

1. etapp: Ninaneelu tampooniproovide valik:
1. Hankige ninaneelu tampooniproov, sisestades steriilse tampooni ninasõõrmesse.
2. Lükake steriilset tampooni, kuni turbinaadi laval tekib takistus.
3. Pöörake steriilset tampooni mitu korda nina -neelu seina poole ja minge
10 sekundiks sellesse kohta, et tampooni otsik küllastuks.
4. Võtke tampoon kiiresti ninasõõrmelt ära.
5. Asetage tampooniproov viirustranspordi puhvertuubi ja sulgege toru tihedalt.
6. Viige tampoonimuster VTM -is jahedas ahelas laborisse.
7. Mustrit saab toatemperatuuril (alla 30 ° C) salvestada kuni 24 tunniks
mustrivalikus või temperatuuril 2–8 ° C koguni 48 tundi alates mustrivaliku ajast.

2. etapp: mustri ettevalmistamine testimiseks:

1. Mustri ettevalmistamine peab toimuma labori BSL-2 astmekapis.
2. Kombineerige tampooniproov kenasti VTM-torusse (keeristage umbes 3-5 sekundit).
3. Lülitage 100 μL VITROS SARS-CoV-2 antigeeni ekstraheerimispuhver otse märgistatud uue mustriga tuubi.
4. Lisage ülaltoodud katsutisse 400 μL viiruse mustrit (et hoolitseda 1: nelja suhtega ekstraheerimispuhvri
ja mustri vahel).

 

COVID-19 Ag Rapid Test, Cs

R0182C 20
EUR 1.25

COVID-19 Ag Self-Test. Cs

R0182CST 1,2,5
EUR 1.65

COVID-19 Ag Rapid Test External Control Kit

C0182 each
EUR 520

Flu A & Flu B & Covid-19 Ag Rapid Test

GF101A3 25 Test/kit Ask for price

Panbio COVID-19 AG RAPID T Device 25T NP

41FK10 25 Tests/Kit
EUR 220

Panbio COVID-19 AG RAPID T DEVICE 25T NS

41FK11 25 Tests/Kit
EUR 123.75
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

COVID-19 + Influenza A. B Ag Rapid Test, Cs

R0188C 1fi Ask for price

COVID-19 Ag Detection Kit (Colloidal Gold Immunochromatography)

MBS398097-20Tests 20Tests
EUR 325

Truenat™ COVID-19

601430005 5T
EUR 60

Truenat™ COVID-19

601430020 20T
EUR 240

Truenat™ COVID-19

601430050 50T
EUR 600

COVID-19 variant pack

SB072 0.5
EUR 2325.81
Description: SARS-CoV-2 Spike (S) glycoprotein:Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein in a class I fusion protein that allows the virus to enter host cells.Variants package available:Some proteins of Sars-CoV-2 are identified as leading targets for COVID-19 therapies. SB-PEPTIDE offers a special pack pre-made peptide libraries of Spike protein including peptides from COVID-19 variants: UK COVID-19 variant B.1.1.7, South Africa COVID-19 variant B.1.351, Brazil COVID-19 variant B.1.1.248. SB-PEPTIDE offers additional plate containing only peptides with Spike S protein mutation of COVID-19 B.1.1.7, B.1.3.5.1 and B.1.1.248 (cited below).Variants package and Spike (S) glycoprotein peptide library can be used for T-cell assays, immune monitoring, antigen specific T-cell stimulation, T-cell expansion and cellular immune response.

COVID-19 Spike Antigen

30-2018 1 mg
EUR 400
Description: COVID-19 Spike recombinant antigen

COVID-19 Spike Antigen

30-2019 1 mg
EUR 400
Description: COVID-19 Spike recombinant antigen

Moderna COVID-19 Vaccine

H7N7-319 1 vial
EUR 798.4
Description: Protein

SARS & COVID-19 coronavirus

3862 each
EUR 330
Description: nucleoprotein

SARS & COVID-19 coronavirus

3863 each
EUR 330
Description: nucleoprotein

SARS & COVID-19 coronavirus

3864 each
EUR 330
Description: nucleoprotein

COVID-19 Negative Control

MBS412771-05mL 0.5mL
EUR 100

COVID-19 Negative Control

MBS412771-5x05mL 5x0.5mL
EUR 305

COVID-19 Nucleocapsid protein

30-2005 1 mg
EUR 700
Description: COVID-19 Nucleocapsid protein recombinant antigen

COVID-19 Nucleocapsid protein

30-2006 1 mg
EUR 700
Description: COVID-19 Nucleocapsid protein recombinant Antigen

Leave a Comment

Your email address will not be published. Required fields are marked *